Incyte Corporation (INCY) Earnings History
Annual and quarterly earnings data from 1993 to 2025
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 91.5% | 26.1% | 25.0% |
| 2024 | 91.1% | 1.9% | 0.8% |
| 2023 | 91.5% | 17.6% | 16.2% |
| 2022 | 92.5% | 17.7% | 10.0% |
| 2021 | 93.7% | 21.3% | 31.8% |
Download Data
Export INCY earnings history in CSV or JSON format
Free sign-in required to download data
Incyte Corporation (INCY) Earnings Overview
As of February 28, 2026, Incyte Corporation (INCY) reported trailing twelve-month net income of $1.29B, reflecting +41.7% year-over-year growth. The company earned $6.28 per diluted share over the past four quarters, with a net profit margin of 0.3%.
Looking at the long-term picture, INCY's historical earnings data spans multiple years. The company achieved its highest annual net income of $1.29B in fiscal 2025, representing a new all-time high.
Incyte Corporation maintains positive profitability with a gross margin of 0.9%, operating margin of 0.3%, and net margin of 0.3%. The company continues to generate positive earnings from operations. View revenue history →
Compared to industry peers including RVMD (-$1.13B net income), GMAB ($6.57B net income, 0.4% margin), EXEL ($678M net income, 0.3% margin), INCY has comparable earnings metrics. Compare INCY vs RVMD →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
33 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.29B | +3845.0% | $1.34B | $6.41 | 25.0% | 26.1% |
| 2024 | $33M | -94.5% | $80M | $0.15 | 0.8% | 1.9% |
| 2023 | $598M | +75.4% | $652M | $2.65 | 16.2% | 17.6% |
| 2022 | $341M | -64.1% | $600M | $1.52 | 10.0% | 17.7% |
| 2021 | $949M | +420.8% | $638M | $4.27 | 31.8% | 21.3% |
| 2020 | -$296M | -166.2% | -$240M | $-1.36 | -11.1% | -9.0% |
| 2019 | $447M | +308.2% | $422M | $2.05 | 20.7% | 19.5% |
| 2018 | $109M | +135.0% | $155M | $0.51 | 5.8% | 8.3% |
| 2017 | -$313M | -400.5% | -$236M | $-1.53 | -20.4% | -15.3% |
| 2016 | $104M | +1495.8% | $164M | $0.54 | 9.4% | 14.8% |
See INCY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs INCY Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare INCY vs AGIO
See how INCY stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is INCY growing earnings?
INCY EPS is $6.28, with earnings growth accelerating to +41.7%. This exceeds the 5-year CAGR of N/A. TTM net income reached $1.3B.
What are INCY's profit margins?
Incyte Corporation net margin is +0.3%, with operating margin at +0.3%. Below-average margins reflect competitive or cost pressures.
How consistent are INCY's earnings?
INCY earnings data spans 1993-2025. The accelerating earnings trend is +41.7% YoY. Historical data enables comparison across business cycles.